Effect of Acupoint Catgut Embedding for Middle-Aged Obesity: A Multicentre, Randomised, Sham-Controlled Trial.
Chen XiaWei HuangDan WeiJi-Ping ZhaoWei ZhangDe-Guang DingYang JiaoHong-Ling PanJia-Jia ZhangFeng ZhongFeng GaoYi-Ting JinYi-Wei ZhengYan-Ji ZhangQiao HuangXian-Tao ZengZhong-Yu ZhouPublished in: Evidence-based complementary and alternative medicine : eCAM (2022)
. ACE for 16 weeks could decrease the waistline and weight and was safe for the treatment of obesity. Further research is needed to evaluate the long-term efficacy and sex differences. This trial is registered with NCT02936973.
Keyphrases
- double blind
- study protocol
- weight loss
- clinical trial
- weight gain
- middle aged
- insulin resistance
- open label
- metabolic syndrome
- phase iii
- high fat diet induced
- placebo controlled
- phase ii
- type diabetes
- randomized controlled trial
- body mass index
- angiotensin ii
- angiotensin converting enzyme
- adipose tissue
- skeletal muscle
- cross sectional
- replacement therapy